Bangkok International Conference on Avian Influenza 2008

The Bangkok International Conference on Avian Influenza 2008 was organized by the National Center for Genetic Engineering and Biotechnology of Thailand. The Center has been playing an active role in the organization of research projects and knowledge management in preparation for an influenza pandemic since the beginning of the H5N1 avian influenza (AI) outbreak in the region in 2004. The timing of the conference, January 23rd, coincided with the 2004 announcement of the first outbreak in the country, marking the fourth year of widespread AI outbreaks in this region. In this 4-year period, progresses have been made scientifically and politically. Nevertheless, AI is still a major threat to us all. At the opening ceremony of the conference, Yongyuth Yuthavong, the Minister of Science and Technology of Thailand, emphasized that we are all together in the global village in this AI crisis and that we have to share information and materials and work together in the fight against this enemy of mankind.

[1]  F. Hayden,et al.  Update on avian influenza A (H5N1) virus infection in humans. , 2008, The New England journal of medicine.

[2]  A. Osterhaus,et al.  Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine , 2008, PloS one.

[3]  A. Kumar,et al.  Three Indonesian Clusters of H5N1 Virus Infection in 2005 , 2008 .

[4]  R. Webby,et al.  Identification of H2N3 influenza A viruses from swine in the United States , 2007, Proceedings of the National Academy of Sciences.

[5]  John Steel,et al.  Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature , 2007, PLoS pathogens.

[6]  G. Leroux-Roels,et al.  Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial , 2007, The Lancet.

[7]  David B. Finkelstein,et al.  Persistent Host Markers in Pandemic and H5N1 Influenza Viruses , 2007, Journal of Virology.

[8]  H. Klenk,et al.  Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. , 2007, Virology.

[9]  K. Nakamura,et al.  Partial protection against challenge with the highly pathogenic H5N1 influenza virus isolated in Japan in chickens infected with the H9N2 influenza virus , 2007, Archives of Virology.

[10]  Y. Guan,et al.  Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract , 2007, Nature Medicine.

[11]  T. B. Usman,et al.  Reduced sensitivity of influenza A (H5N1) to oseltamivir. , 2007, Emerging infectious diseases.

[12]  T. Tumpey,et al.  Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.

[13]  Yi Guan,et al.  Three Indonesian clusters of H5N1 virus infection in 2005. , 2006, The New England journal of medicine.

[14]  D. Fedson.  Pandemic Influenza: A Potential Role for Statins in Treatment and Prophylaxis , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Adolfo García-Sastre,et al.  The guinea pig as a transmission model for human influenza viruses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Kawaoka,et al.  Properties and Dissemination of H5N1 Viruses Isolated during an Influenza Outbreak in Migratory Waterfowl in Western China , 2006, Journal of Virology.

[17]  A. García-Sastre,et al.  Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Zambon,et al.  Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial , 2006, The Lancet.

[19]  S. Dowell,et al.  Human Disease from Influenza A (H5N1), Thailand, 2004 , 2005, Emerging infectious diseases.

[20]  Constance Schultsz,et al.  Avian influenza A (H5N1) in 10 patients in Vietnam. , 2004, The New England journal of medicine.

[21]  R. Webster,et al.  Cross-Reactive, Cell-Mediated Immunity and Protection of Chickens from Lethal H5N1 Influenza Virus Infection in Hong Kong Poultry Markets , 2001, Journal of Virology.

[22]  F. Hayden,et al.  Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. , 2001, The Journal of infectious diseases.

[23]  A. Norman.  Ultraviolet inactivation of poliovirus ribonucleic acid. , 1960, Virology.